CHPA honors Dr. Greg Collier with 2025 Career Achievement Award
“Dr. Collier’s decades of dedication, vision, and leadership embody the spirit of this award,” said CHPA President and CEO Scott Melville.
“Dr. Collier’s decades of dedication, vision, and leadership embody the spirit of this award,” said CHPA President and CEO Scott Melville.
Emma Mittelstaedt Burnham is an experienced antitrust enforcer, exactly what patients and providers need to go up against PBMs and insurers.
CatalinaRx combines deterministic purchase data and predictive audience modeling with the nationwide addressable retail print media network.
The report aims to improve children’s health, but critics say it relies on flawed science and weak regulation.
The patented solution secures prescriptions from pharmacy to medicine cabinet.
“Current research has not established a causal link between acetaminophen use and adverse neurodevelopmental outcomes.”
Time to pass bipartisan measures, say 134 groups.
Project affirms commitment to supporting the domestic pharmaceutical industry and strengthens pharmacy supply chain.
Almost 2 million Texans living in pharmacy deserts and managing multiple chronic conditions can now access over 50 commonly prescribed medications for just $5 a month with free delivery.
The company aims to make FDA approved semaglutide therapies safer and more financially accessible, compared to compounded weight-loss alternatives.
In addition, customers can visit any in-store GIANT or MARTIN’S pharmacy to receive their flu vaccination. Flu and COVID-19 vaccines can be given together.
Kennedy appeared yesterday before the Senate finance committee to testify on his Make America Healthy Again agenda after a tumultuous few weeks that ended with more than 1,000 current and former health agency employees accusing him of “putting the health of all Americans at risk”.
“This temporary order will ensure seamless access while the Governor works with the Legislature on a long-term solution to safeguard access to preventive care and vaccines.”
Located in Hopewell, the new 80,000-sq.-ft. facility represents Enzene’s first major manufacturing investment in the U.S.
Cash flow problems, revenue loss would make participation untenable.
Designed to protect children and empower seniors, it achieves top U.S. safety ratings and meets global accessibility standards.